PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Jun-2021 2021 New research: More successful 'Nanobodies Market' to battle novel Covid | Technology & Innovation, Types, Structure, and Mechanism of Action by 2027 Coherent Market Insights
04-Jun-2021 Global Light Therapy Market 2021 – Growth statistics, top trends, covid-19 impact and forecast 2031 MARKITWIRED
04-Jun-2021 Analytical Laboratory Instrument Global Market Report 2021: COVID-19 Impact and Recovery to 2030 - ResearchAndMarkets.com Businesswire
04-Jun-2021 Initiation of tax incentives to promote qualified clinical trials will magnify the hypoparathyroidism treatment market demand MARKITWIRED
04-Jun-2021 Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin’s Lymphoma Businesswire
04-Jun-2021 SOTIO Presents Positive Biomarker Data from DCVAC/OvCa Phase 2 Study in First Line Ovarian Cancer at the 2021 ASCO Annual Meeting B3C newswire
04-Jun-2021 SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors Businesswire
04-Jun-2021 Rising Frequency of Genetic Mutation Cases Causing Soaring Demand in DNA Polymerase Market MARKITWIRED
04-Jun-2021 Worldwide Irritable Bowel Syndrome (IBS) Diagnostics Industry to 2028 - Increasing Disposable Incomes Present Opportunities - ResearchAndMarkets.com Businesswire
04-Jun-2021 Increase in Incidence of Dengue to Drive Dengue Vaccines Market MARKITWIRED
04-Jun-2021 Popularity of Intravenous Drug Administration Module Fuelling Generic Injectable Market Demand MARKITWIRED
04-Jun-2021 Global Hydrolyzed Collagen Market to 2027 - COVID-19 Impact and Analysis - ResearchAndMarkets.com Businesswire
04-Jun-2021 Novartis continues to push the boundaries of innovation, reimagining medicine, with bold science as it today unveils strong presence at ASCO, including overall survival data in prostate and breast cancer Novartis
04-Jun-2021 Virios Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia Businesswire
04-Jun-2021 Ribon Therapeutics Announces Oral Presentation of Positive Interim Data from Phase 1 Trial of RBN-2397 in Patients with Advanced Solid Tumors at 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Precision BioSciences Reports Progress on Two Strategies Designed to Optimize Durability of Allogeneic CAR T Therapy in R/R Non-Hodgkin Lymphoma Businesswire
04-Jun-2021 GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test Businesswire
04-Jun-2021 4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update Businesswire
04-Jun-2021 Boston Properties Builds on Its Growing Life Sciences Portfolio, Acquires Lab Properties in Waltham, Massachusetts Businesswire
04-Jun-2021 Immutep reports positive final data from the INSIGHT-004 phase I study of LAG-3 therapy, Efti, at ASCO 2021 Immutep Limited